14-day Premium Trial Subscription Sign Up For FreeGet Free
Nasdaq - Total Crash or Bounce-Up? Click To Watch.

$15.58 (2.23%)

Volume: 1.08M

Closed: Sep 26, 2022

Hollow Logo Score: -4.064

Intercept Pharmaceuticals Stock Forecast

$15.58 (2.23%)

Volume: 1.08M

Closed: Sep 26, 2022

Score Hollow Logo -4.064

Discuss ICPT Stock NASDAQ:ICPT Sign in to comment

* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Unlock All Premium Features! Go Premium! Only $19.90/Month

Unlock the Top 5 candidates in every list
Unlock full Ultimate List Builder
Golden Star lists & Auto Portfolios
Possible Runners & Moving Average lists
Ad-free browsing
Save data in PDF

Hot Stocks To Watch:

IMPROVE YOUR TRADING GAME WITH A GOLDEN STAR

From 27 079 stocks, only a few dozen will trigger such a signal!

About Intercept Pharmaceuticals

Intercept Pharmaceuticals Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nona... ICPT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT